Dismembered Pyeloplasty With and Without After Coming Stent
NCT ID: NCT02138877
Last Updated: 2016-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2014-01-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Modified Antegrade Stenting in Laparoscopic Pediatric Pyeloplasty; an Optimized Approach
NCT06697132
Clinical Significance of Supranormal Differential Renal Function in the Recovery of Hydronephrosis
NCT01839006
Cost-Effectiveness and Clinical Outcomes of Double J Stent Versus Percutaneous Feeding Tube Placement Following Open Pyeloplasty in Pediatric Patients: A Prospective Randomized Single-center Study
NCT06847841
Ultrasonographic Versus Renographic Parameters in Prediction of Early Success After Pyeloplasty in Children
NCT03939091
Pediatric Robotic Versus Open Pyeloplasty
NCT04884945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
After coming stent
Dismembered pyeloplasty with insertion of an after coming stent
After coming stent after dismembered pyeloplasty
Dismembered pyeloplasty through lumbar incision. The patients who are randomized to the after coming stent arm, an after coming stent is inserted. Distal part of it is positioned in the mid ureter. The proximal end is passed through the renal parenchyma (usually the lower kidney calyx) to be exteriorized through stab wound and fixed to the skin. The size of external stent is 4-5 F.
Stentless
Stentless dismembered pyeloplasty
Stentless dismembered pyeloplasty
Dismembered pyeloplasty through lumbar incision. No stents are inserted
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
After coming stent after dismembered pyeloplasty
Dismembered pyeloplasty through lumbar incision. The patients who are randomized to the after coming stent arm, an after coming stent is inserted. Distal part of it is positioned in the mid ureter. The proximal end is passed through the renal parenchyma (usually the lower kidney calyx) to be exteriorized through stab wound and fixed to the skin. The size of external stent is 4-5 F.
Stentless dismembered pyeloplasty
Dismembered pyeloplasty through lumbar incision. No stents are inserted
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Asymptomatic obstruction with reduced function (less than 35-40%)
* Asymptomatic obstruction with antero-posterior diameter exceed 40 mm
* Asymptomatic obstruction with deterioration on conservative follow up.
* Symptomatic PUJ obstruction, e.g. pain, renal mass, fever and stones.
Exclusion Criteria
* Solitary kidney
* Gross pyuria
* Ectopic kidney
* Dilated ureter
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
mohammed said elsheemy
Associte professor of urology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohammed S ElSheemy, A professor
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University Hospitals
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
61178
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.